Werlinich Asset Management, LLC Gilead Sciences, Inc. Transaction History

Werlinich Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Nov 13, 2023	SELL	$57.92 - $72.58 $819,278 - $1.03 Million	-14,145 Closed	0 $0
Q4 2021 Nov 13, 2023	SELL	$64.88 - $73.64 $13,624 - $15,464	-210 Reduced 1.46%	14,145 $1.03 Billion
Q2 2021 Nov 13, 2023	SELL	$63.47 - $69.35 $26,974 - $29,473	-425 Reduced 2.88%	14,355 $988 Million
Q1 2021 Nov 13, 2023	BUY	$60.0 - $68.46 $886,800 - $1.01 Million	14,780 New	14,780 $955 Million

1,880

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Werlinich Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Werlinich Asset Management, LLC with notifications on news.